 |
|
|
|
 |
egories |
 |
|
|
 |
New Sites - Main » Business » Biotechnology and Pharmaceuticals » Cancer Research |
 |
|
PNP Therapeutics, Inc. (27th April, 2005) : Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
|
|
Onyvax Ltd. (27th April, 2005) : Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their ...
|
|
Aventis Cancer Vaccine Program (27th April, 2005) : Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.
|
|
Biomoda, Inc. (27th April, 2005) : Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico ...
|
|
Crusade Laboratories Ltd. (27th April, 2005) : Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK.
|
|
Top Sites - Main » Business » Biotechnology and Pharmaceuticals » Cancer Research |
|
Biomoda, Inc. ( ) : Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico
|
|
InterGenetics Inc. () : Company with platform technology, called CombiSNiP, that genetically quantifies an individual's risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City
|
|
Aventis Cancer Vaccine Program () : Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.
|
|
AC Immune SA. () : Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.
|
|
PNP Therapeutics, Inc. () : Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
|
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|
